Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Search results

[Ad-hoc-Mitteilung gemäss Art. 53 KR] Roche erzielt starkes Jahresergebnis für 2025 mit Verkaufswachstum von 7%

Konzernverkäufe stiegen um 7%¹ zu konstanten Wechselkursen (CER; 2% in CHF) dank hoher Nachfrage nach Medikamenten und diagnostischen Lösungen.
Im vierten Quartal nahm der Umsatz um 8% zu und

GlobeNewswire

RHHBY's 2025 Results Hit by Currency Headwinds, Sales Up 7% at CER

Swiss pharma giant Roche Holding AG's RHHBY 2025 results were affected by currency headwinds.

Sales totaled $74.4 billion, which missed the Zacks Consensus Estimate of $81.4 billion. Earnings per

Zacks

QGEN's Q4 Earnings Meet Estimates, Revenues Up Y/Y, Stock Down

QIAGEN N.V.’s QGEN fourth-quarter 2025 adjusted earnings per share (EPS) were 62 cents, the same at the constant exchange rate (CER). The reported figure increased 1.6% on a year-over-year basis

Zacks